ADARx Pharmaceuticals Funding: $200M Raised, Series C (2023)
ADARx Pharmaceuticals is based in San Diego. It has raised $200M in total funding. Latest round: Series C.
ADARx Pharmaceuticals funding overview
ADARx Pharmaceuticals is based in San Diego. ADARx Pharmaceuticals has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2023. The round record for ADARx Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, TCGX, Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare Investments and 10 others. 16 distinct backers are named across the disclosed rounds.
ADARx Pharmaceuticals at a glance
Total raised
$200M
Latest round
Series C
Latest round date
August 2023
Headquarters
San Diego
Notable investors
Bain Capital Life Sciences, TCGX, Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare Investments, Invus, Marshall Wace
Frequently asked about ADARx Pharmaceuticals funding
How much has ADARx Pharmaceuticals raised?
ADARx Pharmaceuticals has raised $200M in total disclosed funding across the rounds on record.
Who has invested in ADARx Pharmaceuticals?
Bain Capital Life Sciences, TCGX, Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare Investments are named among the investors backing ADARx Pharmaceuticals.
What was the latest ADARx Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in August 2023.
Where is ADARx Pharmaceuticals based?
ADARx Pharmaceuticals is based in San Diego.
When did ADARx Pharmaceuticals last raise?
The last disclosed ADARx Pharmaceuticals round closed in August 2023 at Series C.
Round data for ADARx Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.
